No Need to Put Surgeries on Hold: Nephron Pharmaceuticals Corp. has Sterile Sodium Bicarbonate Available
WEST COLUMBIA, S.C., June 20, 2017 /PRNewswire/ -- Nephron Pharmaceuticals Corporation (Nephron) has recently tripled their production of Sodium Bicarbonate to help alleviate the nationwide shortage.
Nephron is distributing Sodium Bicarbonate to hospitals across the United States from the new 503B Outsourcing Division. The company is opening new accounts in record numbers to remedy the crisis caused by the recent shortage.
Nephron releases batches of the Sodium Bicarbonate, only after, all release data is available and passing. The company stands by its commitment to distribute only the highest quality medication.
The Nephron 503B Outsourcing Facility is FDA inspected and operates certified clean rooms using current Good Manufacturing Practices (cGMP). All products are manufactured on fully validated equipment and are verified with advanced in-house analytical, chemistry and microbiological testing.
Nephron produces 1+ billion sterile doses annually from its award winning West Columbia, South Carolina location.
Hospitals and surgery centers can contact the Nephron 503B Outsourcing Facility toll free at 1-844-224-2225 or email [email protected].
About Nephron
Nephron Pharmaceuticals Corporation is a woman owned, private manufacturer of generic respiratory medications, ophthalmic and injectable drugs. As an industry leader in product safety and quality, Nephron offers individually wrapped and bar-coded medication. These products are available to retail pharmacies, hospitals, home care companies, long term care facilities, mail order pharmacies, and surgical centers. The company has been approved by the Food and Drug Administration as a sterile manufacturer of generic respiratory medications along with a new outsourcing facility providing equal sterility and quality. Nephron recently received an ISPE / FOYA 2017 innovation award for the high level of automation present throughout the facility. For more information, please visit www.nephronpharm.com.
SOURCE Nephron Pharmaceuticals Corporation
Share this article